How to Get Semaglutide or Tirzepatide Without Insurance in 2026
A guide to comparing GLP-1 access routes, current pricing, and program terms.
Patients without insurance often have to compare brand cash-pay pricing, manufacturer support options, telehealth programs, and legitimate compounded-access routes. This guide focuses on how to evaluate those options safely and how to avoid stale price claims when comparing semaglutide or tirzepatide access.
Comparing Cost Information
GLP-1 Medication Costs Without Insurance
| Medication | Brand Cash-Pay | Compounded | Telehealth Programs |
|---|---|---|---|
| Semaglutide access routes | Verify current manufacturer cash-pay terms | Varies by prescriber and pharmacy workflow | Varies by program inclusions and support model |
| Tirzepatide access routes | Verify current manufacturer cash-pay terms | Varies by access route and regulatory context | Varies by program inclusions and support model |
Compounded GLP-1 Medications
Read the compounded semaglutide safety guide for questions to discuss with a licensed provider.
What Is Compounding?
Compounding pharmacies create customized medications based on a licensed provider's prescription. Regulatory context, shortage status, and pharmacy type all matter here, so patients should avoid articles that treat every compounded-access question as identical across products and dates.
Pharmacy Information to Verify
- State-licensed 503A community sterile-compounding pharmacy
- State pharmacy board licensed
- Based in the United States
- Requires valid prescription from licensed provider
Compounded Medication Costs
Compounded Semaglutide
- Monthly cost: Varies by pharmacy, formulation, and support model
Compounded Tirzepatide
- Monthly cost: Varies by access route, pharmacy, and supply conditions
Telehealth Weight Loss Programs
Trimi's Current Cash-Pay Plans
Trimi's published plans show the monthly equivalent and the full charge for each compounded treatment and billing term.
Prices verified October 2026 (UTC).
| Billing term | Compounded semaglutide | Compounded tirzepatide |
|---|---|---|
| Monthly | $175 each month$175/month | $235 each month$235/month |
| Quarterly | $435 every 3 months$145/month equivalent | $597 every 3 months$199/month equivalent |
| 6 months | $720 upfront$120/month equivalent | $1,050 upfront$175/month equivalent |
| Annual12-month commitment | $1,188 upfront$99/month equivalent | $1,500 upfront$125/month equivalent |
The monthly equivalent is the term price divided by its months. Payment-provider installments do not change the underlying billing term. Review the amount due and terms before paying.
Monthly plans have no multi-month commitment: compounded semaglutide is $175 billed monthly and compounded tirzepatide is $235 billed monthly. Monthly and quarterly plans renew automatically unless renewal is turned off. The 6-month and annual plans do not renew automatically. Continuing after the term ends requires a provider check-in and choosing and confirming a plan at checkout, and no new term is charged without it. Turning off renewal does not cancel a term already paid for.
Manufacturer Savings Programs
Wegovy Savings Card
- For commercially insured: Program terms may lower out-of-pocket cost if eligibility requirements are met
- For uninsured: Verify the current manufacturer offer directly before relying on it
Zepbound Savings Card
- For commercially insured: Current savings terms should be checked directly with Lilly
- Cash-pay option: Verify the current direct-purchase terms with Lilly before comparing programs
What to Avoid
Red Flags When Seeking Affordable GLP-1s
- • No prescription required: Avoid sellers offering prescription medication without a valid prescription.
- • Prices too good to be true: May indicate counterfeit or diluted products
- • Social media sellers: High risk of counterfeit medications
- • No medical oversight: Safe use requires provider monitoring
Conclusion
Key takeaways:
- Always verify pharmacy credentials and require a prescription
- Compare the full amount charged and the length of the commitment, not only a monthly equivalent.
- Check renewal and refund terms before paying. Turning off renewal does not cancel a term already paid for.
Ready to Start Your Weight Loss Journey?
Get Started TodayMore on cost & affordability
Sources & References
- Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
- Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
- Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
- FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any medication or treatment program.